Become an Investor in revolutionary new AI Technology

INVEST NOW IN
S A F E S T R I D E®

Empowering Recovery Through Revolutionary AI Driven VR Innovation


An AI platform delivering real-time therapy management & tracking
tapping into a $100BN global market

AN INVESTMENT
IN AI POWERED
VR THERAPY

Engaging - Personalized - Effective


Reducing Therapy Time with better therapy outcomes for patient and therapist
real-time tracking | real-time therapy | real-time results

AI TAILORED THERAPY

Outpacing Competitors with
AI-Powered Customization


Patent Pending AI Solutions driving new therapist revenue

Welcome to our Pre-Seed funding round raising up to $1M under SEC Reg.D Rule 506(b) for Accredited and Non-Accredited Investors.

SSIT is the new Therapy Standard for VR rehabilitation by improving outcomes and reducing therapy time.
Find out about Investing NOW.



50M people of all ages annually undergo rehab therapy in the US yearly and many more globally. But traditional rehab is slow, expensive, and lacks personalization. Limited access to quality care and tracking, limits outcomes. SSIT overcomes these problems for patients and therapists globally and Outpacing Competitors with AI-Powered Customization. SSIT provides better therapy tools for therapistter and better outcomes for patients.

Schedule an Investment Call Now







Download our Investment Materials Below and read our Investment Disclaimer

Click on each link to view our Investment Products. If you need a hard copy of the document please email us at: vikahl@gmail.com.

For Accredited and limited Non-Accredited Investors

A new investment offer providing outstanding opportunities for all investors - anywhere.



Our new SSIT Pre-Seed Funding round starts November 15, 2024. Download the brochure plus our other investment documents to learn more about this exciting new investment offer. Investment starts at $25K, but hurry this is a limited offer. Click the link below and schedule an obligation-free investment call.
Contact Us Now




Our Research leads the way

Review Article American Journal of Biomedical Science & Research proves it.

Outstanding performance significantly beating traditional and conventional therapy across six major treatment protocols. This review shows the promise of efficacy of the Virtual Reality (VR) rehabilitation and suggests that it is suitable, effective, superior or at least complementary to the traditional Physical Therapy and Rehabilitation process may be a potential tool for neurotherapy, neuro-rehabilitation, and fall prevention in children, young adults and geriatrics population. IRB Trials approved in neuro-rehabilitation tests for 2025.



Get the Paper Here


Our Case Studies show how effective SSIT is over Traditional Therapy even current VR.


Case Study: The Role of Virtual Reality in Vestibular Rehabilitation

At Safe Stride Immersive Therapy (SSIT), we are revolutionizing rehabilitation through the use of AI-driven Virtual Reality (VR) technology. This case study highlights the transformative potential of VR in addressing balance and mobility challenges in patients with vestibular disorders. By providing immersive, engaging, and customizable therapy, VR complements traditional approaches to improve patient outcomes, boost confidence, and enhance adherence to rehabilitation programs. Below, we outline the key advantages of incorporating VR into rehabilitation therapy.


  1. Engagement and Motivation: The immersive nature of VR gamifies rehabilitation, making exercises more engaging and improving patient adherence.
  2. Controlled Environment: VR allows therapists to adjust variables like movement, speed, and visual stimuli, creating customizable experiences that can be safely intensified.
  3. Safe Simulation of Real-World Scenarios: Patients can practice challenging tasks, such as navigating crowded spaces or uneven surfaces, in a risk-free environment.
  4. Real-Time Feedback: VR provides immediate feedback, enabling patients to refine movements and improve performance during exercises.
  5. Remote Accessibility: VR enables remote therapy, allowing patients to continue their rehabilitation at home under the guidance of a therapist, improving accessibility and convenience.


Finding the right investment for everyone.

SSIT is different from any other AR/VR Rehabilitation platform for real-time therapy management and tracking.


Our global solution will drive revenue for therapists globally and create a unique investment opportunity.

Our Journey in the Rehab world started in 1996. We have consistently evolved and grown in the Physical Therapy and Rehab field with multiple clinics and community reach initiatives . We have been relentlessly working in the innovative field of AI, VR and AR for the last 5 years with clinical trials, cutting edge technology and highly qualified team members to bring our futuristic products in the market..

Safe Stride is at the forefront of healthcare technology innovation. We have developed a suite of cutting-edge technologies that enhance patient care, including: ● A Proprietary AI Platform that analyzes patient data to personalize treatment plans, predict outcomes, and monitor progress. ● AR-Enabled Exercise Guidance providing real-time feedback and visual aids for proper exercise form and technique. ● VR-Immersive Rehabilitation offering gamified experiences and virtual simulations for pain management, balance training, and motor skill development. ● Multi-sensory Immersive Environments that combines visual, auditory, and haptic feedback to enhance rehabilitation outcomes.

At Safe Stride our Mission is to change the way the world experiences Physical Therapy and Rehabilitation. Our Virtual Reality devices using innovative immersive environment and Augmented Reality mobile app with our propriety programs are the futuristic solutions for all your Rehabilitation and Mobility needs..

IMPORTANT DISCLOSURE AND DISCLAIMER


SAFE STRIDE IMMERSIVE THERAPY AND IMMERSIVE MEDICAL SOLUTIONS, ARE NOT REGISTERED BROKER-DEALER, FUNDING PORTAL, OR INVESTMENT ADVISER. THE INFORMATION ON THIS WEBSITE DOES NOT CONSTITUTE INVESTMENT ADVICE AND SHOULD NOT BE RELIED UPON AS SUCH. THE INFORMATION ON THIS SITE IS FOR DISCUSSION PURPOSES ONLY AND IS NOT AN OFFER OR SOLICITATION TO PURCHASE OR SELL ANY SECURITIES OR FINANCIAL PRODUCTS. NONE OF THE INFORMATION ON THIS SITE TAKES INTO ACCOUNT ANY PERSON’S FINANCIAL CIRCUMSTANCES, OR NEEDS AND YOU MUST DETERMINE WHETHER THE INFORMATION IS APPROPRIATE IN TERMS OF YOUR PARTICULAR CIRCUMSTANCES. WE RECOMMEND YOU OBTAIN FINANCIAL, LEGAL AND TAXATION ADVICE BEFORE MAKING ANY FINANCIAL INVESTMENT DECISION.
SSIT is the next Investment Superstar

SSIT has Patent Pending AI Solutions ahead of the competition globally.

Our IP includes Provisional Patent protection as well as proprietary AI algorithms and a full suite of VR software programs. Provisional Patent: USPTO 63/724,266.

SSIT TRANSFORMS CURRENT VR TREATMENT PROTOCOLS

SSIT combines VR therapy with generative AI to deliver real-time tracking and therapy monitoring. It keeps therapy on-track while engaging the patient with gamified rewards, education and a range of therapeutic programs.

Our AI Platform delivers Real-Time programs for Treatment Management & Monitoring

Monitoring and Managing treatment in-clinic as well as at-home for multiple concurrent patients. By tracking real-time both patients and therapists know exactly where they are up to and therapy burn-out is reduced, providing better outcomes and shorter therapy times.


GAMIFIED PATIENT APP KEEPS PATIENTS ON TRACK AND MOVING AHEAD WITH THEIR RECOVERY

Android

IOS

Windows




Rehab is a growing global market ready for disruption


$110BN

Global Market

50
M

Annual US Patients

440
k

US Licensed Therapists

39
k

Target US Therapists



Why Therapists Want SSIT

Because it drives new revenue streams with multiple unit capacity and has better treatment outcomes.

With over thirty years experience and running multiple clinics and treating thousands of patients, we understand the problems and limitations of current therapy. The SSIT concept was the center of a 'straw poll' to dozens of peer therapists and was overwhelmingly supported. Our lease program also helps therapists pay-as-they-go, reducing purchase pushback. Because we are using trusted leverage from our distribution partners, we believe therapists will quickly come to SSIT because it pays for itself. with fewer than 10% of the current licensed therapists marketplacre across the USA as our five-year target, we believe we can capture this market as technology early-adopters. [*See below study: Published Study 2024 - Amercian Journal Biomedical Science & Research.



Insurance Code 0770T driving new revenue by

25

*Reduces therapy time by

30

*Better therapy outcomes by

40
why investors should consider SSIT

Most investment classes are suffering and there is plenty of uncertainty ahead - But not MedTech platforms like SSIT.


On top of potential ROI - here are two more strong reasons to invest in SSIT's Pre-Seed Funding Round.


IRS Code 1244 Stock: A money back Investment up to $1M

Section 1244 encourages investment in small businesses by offering a significant tax break on losses. If you sell or exchange Section 1244 stock at a loss, it can be deducted as an ordinary loss, offsetting ordinary income and providing greater tax savings than capital loss deductions. Individual taxpayers can deduct up to $50,000 ($100,000 for joint filers) annually, compared to the $3,000 limit for capital losses.

To qualify, the stock must be issued by a domestic small business meeting specific criteria, further reducing investor risk and supporting startups like SSIT and it covers the full $1M raise.

SEC Reg D Rule 506(b) Offering by Convertible Note

Benefits of the Convertible Note Offering: Offering investment under Reg D, Rule 506(b) with a convertible note provides several key benefits. Investors earn 7.5% interest over an 18-month term or less, while also receiving a 25% discount upon conversion to equity, enhancing their ownership stake compared to direct equity investors. This structure offers a combination of predictable returns and the potential upside of equity participation, with reduced initial risk since it begins as debt. For a $100,000 investment, the 25% discount means the investor would convert to 133,333 shares ($133,000) at a $1 per share price, maximizing their equity position upon conversion.

Key people

Meet our team

Our Senior Management Team

Dr. Vik Ahluwalia

CEO-Founder

Dr. Vik holds a Doctor of Physical Therapy from Massachusetts General Hospital IHP, affiliated with Harvard University, and an MBA in Business Finance from the University of Alabama. Since 1993, he has owned and operated Professional Physical Therapy and Rehab Centers in Michigan. With over 30 years of experience, Dr. Vik specializes in treating balance, vertigo, BPPV, neurological conditions, and rehabilitation for auto, work-related, and personal injuries. His deep expertise in patient condition analysis and personal injury cases distinguishes him in the field

Dr. Smita Ahluwalia

Co-Founder

Dr. Smita, a Doctor of Physical Therapy graduate from Massachusetts General Hospital IHP, an academic affiliate of Harvard University, serves as the chief clinician, overseeing patient care, documentation, facility operations, and employee training. She develops and implements policies to ensure efficient and high-quality rehabilitative services. Specializing in orthopedics, sports medicine, and women's health rehabilitation, Dr. Smita has also created treatment protocols for balance, vertigo, BPPV, and other neurological conditions.

Brad Duffy

COO

Brad brings over 35 years of business experience, underpinned by a multidisciplinary background in Science, Law, and an MBA. As a successful entrepreneur with multiple startups and exits, he offers a proven track record in building and scaling businesses. Brad is a seasoned business coach and mentor, specializing in Med-Tech, SaaS, Blockchain Platforms, and CRMs. His expertise extends to guiding companies through market strategy, financial modeling, investor relations, and regulatory compliance.

See more of our Team and Advisors in our Business Plan and Pitch Deck


Why Invest Now?

"For illustrative purposes: A $25,000 early-stage investment in Penumbra, made before their launch, grew into millions within five years as the company went public. We believe SSIT is positioned for a similar trajectory of growth. Combined with the tax benefits of IRS Code 1244 Stock, an early investment in SSIT represents a compelling win-win opportunity for forward-thinking investors."


Please see our investment disclaimers - this is an example only and not evidence that SSIT will achieve the same results.
Sam Wilson

SSIT Interim Business Manager

Feedback

Safe Stride Immersive Therapy AI Platform.

Call Dr. Vik Ahluwalia: (248) 301-9219
Find out More about this new AI MedTech investment opportunity with SSIT that is changing rehabilitation therapy globally.